Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Josias B Grogg

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Urology|December 18, 2019
Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series DataChristian D Fankhauser, Josias B Grogg, Stefanie Hayoz, et al.
The Journal of Urology|February 1, 2020
Reply by AuthorsChristian D Fankhauser, Josias B Grogg, Stefanie Hayoz, et al.
Frontiers in Oncology|December 26, 2022
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrenceAilsa J Christiansen, João Lobo, Christian D Fankhauser, et al.
British Journal of Cancer|December 16, 2021
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumoursChristian D Fankhauser, Ailsa J Christiansen, Christian Rothermundt, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Urology|December 18, 2019
Risk Factors and Treatment Outcomes of 1,375 Patients with Testicular Leydig Cell Tumors: Analysis of Published Case Series DataChristian D Fankhauser, Josias B Grogg, Stefanie Hayoz, et al.
The Journal of Urology|February 1, 2020
Reply by AuthorsChristian D Fankhauser, Josias B Grogg, Stefanie Hayoz, et al.
Frontiers in Oncology|December 26, 2022
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrenceAilsa J Christiansen, João Lobo, Christian D Fankhauser, et al.
British Journal of Cancer|December 16, 2021
Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumoursChristian D Fankhauser, Ailsa J Christiansen, Christian Rothermundt, et al.
Pageof 1